EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity

Yaoyuan Zhang iD, Rhiannon Morris iD, Grant J Brown iD, Ayla May D Lorenzo iD, Xiangpeng Meng iD, Nadia J Kershaw iD, Pamudika Kiridena iD, Gaétan Burgio iD, Simon Gross iD, Jean Y Cappello iD, Qian Shen, Hao Wang iD und 23 weitere

Journal of Experimental Medicine · 2024

DOI: 10.1084/jem.20221080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Yaoyuan Zhang und 34 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Acton, Australia. Hauptthemen laut MEDLINE: Autoimmunity, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Wellcome Trust, National Health and Medical Research Council, National Collaborative Research Infrastructure Strategy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with a clear genetic component. While most SLE patients carry rare gene variants in lupus risk genes, little is known about their contribution to disease pathogenesis. Amongst them, SH2B3—a negative regulator of cytokine and growth factor receptor signaling—harbors rare coding variants in over 5% of SLE patients. Here, we show that unlike the variant found exclusively in healthy controls, SH2B3 rare variants found in lupus patients are predominantly hypomorphic alleles, failing to suppress IFNGR signaling via JAK2-STAT1. The generation of two mouse lines carrying patients’ variants revealed that SH2B3 is important in limiting the number of immature and transitional B cells. Furthermore, hypomorphic SH2B3 was shown to impair the negative selection of immature/transitional self-reactive B cells and accelerate autoimmunity in sensitized mice, at least in part due to increased IL-4R signaling and BAFF-R expression. This work identifies a previously unappreciated role for SH2B3 in human B cell tolerance and lupus risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityLupus Erythematosus, SystemicAnimalsHumansMiceB-Cell Activating FactorB-LymphocytesPrecursor Cells, B-LymphoidAdaptor Proteins, Signal Transducing

Substanzen

B-Cell Activating FactorSH2B3 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Acton, Australia.
  • Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Acton, Australia.
  • Walter and Eliza Hall Institute of Medical Research , Parkville, Australia.
  • Department of Medical Biology, The University of Melbourne, Parkville, Australia.
  • Division of Genome Sciences and Cancer, John Curtin School of Medical Research, The Australian National University, Acton, Australia.
  • Francis Crick Institute , London, UK.

ORCID-Profile: Yaoyuan Zhang, Rhiannon Morris, Grant J Brown, Ayla May D Lorenzo, Xiangpeng Meng, Nadia J Kershaw, Pamudika Kiridena, Gaétan Burgio, Simon Gross, Jean Y Cappello, Hao Wang, Cynthia Turnbull, Tom Lea-Henry, Maurice Stanley, Zhijia Yu, Fiona D Ballard, Aaron Chuah, James C Lee, Ann-Maree Hatch, Anselm Enders, Seth L Masters, Alexander P Headley, Peter Trnka, Jeffery T Fletcher, Giles D Walters, Mario Šestan, Marija Jelušić, Matthew C Cook, Vicki Athanasopoulos, David A Fulcher, Jeffrey J Babon, Carola G Vinuesa, Julia I Ellyard

Förderung

  • Wellcome Trust
  • National Health and Medical Research Council
  • National Collaborative Research Infrastructure Strategy
  • Australian Government
  • National Computational Infrastructure

Zitieren

APA

Zhang, Y., Morris, R., Brown, G. J., Lorenzo, A. M. D., Meng, X., Kershaw, N. J., Kiridena, P., Burgio, G., Gross, S., Cappello, J. Y., Shen, Q., Wang, H., Turnbull, C., Lea-Henry, T., Stanley, M., Yu, Z., Ballard, F. D., Chuah, A., Lee, J. C., …, & Ellyard, J. I. (2024). Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20221080

Vancouver

Zhang Y, Morris R, Brown GJ, Lorenzo AMD, Meng X, Kershaw NJ, et al. Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20221080

BibTeX
@article{Zhang2024,
  author = {Zhang, Yaoyuan and Morris, Rhiannon and Brown, Grant J and Lorenzo, Ayla May D and Meng, Xiangpeng and Kershaw, Nadia J and Kiridena, Pamudika and Burgio, Gaétan and Gross, Simon and Cappello, Jean Y and Shen, Qian and Wang, Hao and Turnbull, Cynthia and Lea-Henry, Tom and Stanley, Maurice and Yu, Zhijia and Ballard, Fiona D and Chuah, Aaron and Lee, James C and Hatch, Ann-Maree and Enders, Anselm and Masters, Seth L and Headley, Alexander P and Trnka, Peter and Mallon, Dominic and Fletcher, Jeffery T and Walters, Giles D and Šestan, Mario and Jelušić, Marija and Cook, Matthew C and Athanasopoulos, Vicki and Fulcher, David A and Babon, Jeffrey J and Vinuesa, Carola G and Ellyard, Julia I},
  title = {Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity},
  journal = {Journal of Experimental Medicine},
  year = {2024},
  doi = {10.1084/jem.20221080}
}
Kostenlos starten →